AIThe Decoderabout 2 hours ago
AI drug reverses aging markers in trial
1 min read
Rentosertib, an AI-designed drug by Insilico Medicine, may reverse biological aging markers. Six aging clocks predicted treated patients were up to six years younger biologically than placebo. The trial included 42 patients, and the drug hasn't been tested in healthy people yet.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
